What keeps thisNew York Times piece on clinical and moral interventions at the end of life from degenerating into an “also-Schiavo” piece is that it really reads like a set of cases where bioethics conversations are both necessary and effective. Jessica Berg of Case (and our new Book Review editor along with Mark Aulision) comments.
Labels: end of life, New York Times
